<--- Back to Details
First PageDocument Content
Biotechnology / Inborn errors of purine-pyrimidine metabolism / Uric acid / PEGylation / Pharmacokinetics / Pegloticase / Urate oxidase / Polyethylene glycol / Gout / Hyperuricosuria / Hyperuricemia / Ethylene oxide
Date: 2016-07-11 16:53:34
Biotechnology
Inborn errors of purine-pyrimidine metabolism
Uric acid
PEGylation
Pharmacokinetics
Pegloticase
Urate oxidase
Polyethylene glycol
Gout
Hyperuricosuria
Hyperuricemia
Ethylene oxide

AGGREGATE-FREE URATE OXIDASE FOR PREPARATION OF NON-IMMUNOGENIC POLYMER CONJUGATES - European Patent Office - EPB1 AGGREGATE-FREE URATE OXIDASE FOR PREPARATION OF NON-IMMUNOGENIC POLYMER CONJUGATE

Add to Reading List

Source URL: www.mvpharm.com

Download Document from Source Website

File Size: 1,02 MB

Share Document on Facebook

Similar Documents

Biotechnology, BS

Biotechnology, BS "DBEFNJD.BQ  5IF"DBEFNJD.BQTFSWFTBTBTVHHFTUFEDPVSTFTFRVFODFPOMZ4UVEFOUTBSFOPUMJNJUFEUPUIJTQMBOJUJTNFBOUUPCFVTFEBT

DocID: 1xTqy - View Document

PDF Document

DocID: 1wroO - View Document

Building A Better Mousetrap:  Patenting Biotechnology In The European Community

Building A Better Mousetrap: Patenting Biotechnology In The European Community

DocID: 1vr7C - View Document

BIOTECH & PHARMA IN FRANCE KEY FACTS & FIGURES ¾¾ The French biotechnology sector ranks number 3 in Europe with more than 400 companies behind the UK and Germany ¾¾ First producer of medicines in Europe with 220 prod

BIOTECH & PHARMA IN FRANCE KEY FACTS & FIGURES ¾¾ The French biotechnology sector ranks number 3 in Europe with more than 400 companies behind the UK and Germany ¾¾ First producer of medicines in Europe with 220 prod

DocID: 1vq6b - View Document

Biotechnology Consultation Agency Response Letter BNF

Biotechnology Consultation Agency Response Letter BNF

DocID: 1vpUZ - View Document